Angiotensin-converting enzyme (ACE) inhibitors should be used with caution in patients with CCM, as they may worsen renal function and exacerbate the existing vasodilation associated with advanced cirrhosis170. The gene discussed is ACE; the disease is cerebral cavernous malformation.